Liver cT1 predicts clinical outcomes in patients with chronic liver disease

Liver cT1 predicts clinical outcomes in patients with chronic liver disease

Detalhes bibliográficos
Principais autores:	Jayaswal, A, Pavlides, M, Banerjee, R, Kelly, M, Barnes, E, Neubauer, S
Formato:	Conference item
Idioma:	English
Publicado em:	Elsevier 2019

Registros relacionados

Liver cT1 predicts clinical outcomes in patients with chronic liver disease, equivalent to biopsy
por: Jayaswal, A, et al.
Publicado em: (2018)

Liver cT1 decreases following direct acting antiviral therapy in patients with chronic hepatitis C virus
por: Jayaswal, A, et al.
Publicado em: (2020)

Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
por: Pavlides, M, et al.
Publicado em: (2015)

Reply to: "Multiparametric magnetic resonance imaging to predict clinical outcomes in patients with chronic liver disease: a cautionary note on a promising technique".
por: Pavlides, M, et al.
Publicado em: (2016)

Multi-parametric MRI predicts clinical outcomes in unselected patients with liver disease - a non-invasive test that meets the AASLD criteria for clinical trials?
por: Pavlides, M, et al.
Publicado em: (2014)

Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood‐based fibrosis markers in patients with chronic liver disease
por: Jayaswal, ANA, et al.
Publicado em: (2020)

Multi-parametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity
por: Pavlides, M, et al.
Publicado em: (2017)

Liver function assessment using magnetic resonance imaging with gadoxetic acid administration
por: Levick, C, et al.
Publicado em: (2018)

Estimation of Liver Collagen Proportionate Area by Visual Inspection
por: Pavlides, M, et al.
Publicado em: (2014)

Estimation of Liver Collagen Proportionate Area by Visual Inspection
por: Pavlides, M, et al.
Publicado em: (2014)

Non-alcoholic fatty liver disease
por: Pavlides, M, et al.
Publicado em: (2019)

The importance of the fatty acid transporter L-carnitine in non-alcoholic fatty liver disease (NAFLD)
por: Savic, D, et al.
Publicado em: (2020)

Quantifying the heterogeneity of liver inflammation and fibrosis in primary sclerosing cholangitis using the interquartile range of iron‐corrected T1 from multi‐parametric MRI
por: Selvaraj, E, et al.
Publicado em: (2019)

A model for hepatic fibrosis: The competing effects of cell loss and iron on shortened Modified Look-Locker inversion recovery T1 (shMOLLI-T1) in the liver
por: Tunnicliffe, E, et al.
Publicado em: (2016)

Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease.
por: Banerjee, R, et al.
Publicado em: (2014)

Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease
por: Banerjee, R, et al.
Publicado em: (2014)

Multi-parametric MRI techniques for the non-invasive assessment of patients with liver disease
por: Pavlides, M
Publicado em: (2015)

Improving Medication‐Related Outcomes in Chronic Liver Disease
por: Kelly L. Hayward, et al.
Publicado em: (2020-11-01)

A combination model of CT-based radiomics and clinical biomarkers for staging liver fibrosis in the patients with chronic liver disease
por: Maowen Tang, et al.
Publicado em: (2024-08-01)

Interobserver variability in histologic evaluation of liver fibrosis using categorical and quantitative scores
por: Pavlides, M, et al.
Publicado em: (2017)

A short-term predictive model for disease progression in acute-on-chronic liver failure: integrating spectral CT extracellular liver volume and clinical characteristics
por: Yuan Xu, et al.
Publicado em: (2025-03-01)

Reply to: non-invasive tests and advanced chronic liver disease in NAFLD: two steps forward and one step back?
por: Pavlides, M, et al.
Publicado em: (2021)

Impact of Liver Test Abnormalities and Chronic Liver Disease on the Clinical Outcomes of Patients Hospitalized with COVID-19
por: Mónica Garrido, et al.
Publicado em: (2021-01-01)

Non-invasive markers of liver fibrosis: adjuncts or alternatives to liver biopsy?
por: Chin, J, et al.
Publicado em: (2016)

Sarcopenia in children with chronic liver disease: Prevalence and impact on liver transplant outcomes
por: Silvio Veraldi, et al.
Publicado em: (2022-10-01)

Fasting plasma insulin concentrations are associated with changes in hepatic fatty acid synthesis and partitioning prior to changes in liver fat content in healthy adults
por: Hodson, L, et al.
Publicado em: (2016)

Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease.
por: Jack X Q Pang, et al.
Publicado em: (2014-01-01)

CT Evaluation of Liver Hydatid Disease
por: May Khalid Ameen
Publicado em: (2007-04-01)

Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [18F]fluorocholine PET/CT
por: Sandi A. Kwee, et al.
Publicado em: (2015-05-01)

ACUTE HEPATITIS С ON THE BACKGROUND OF LIVER Cirrhosis IN THE OUTCOME OF CHRONIC HEPATITIS C: CLINICAL CASE
por: V. G. Morozov, et al.
Publicado em: (2018-01-01)

Early prediction of acute-on-chronic liver failure development in patients with diverse chronic liver diseases
por: Yuqiang Shen, et al.
Publicado em: (2024-11-01)

Liver HLA-E Expression Is Associated with Severity of Liver Disease in Chronic Hepatitis C
por: Roberta C. Araújo, et al.
Publicado em: (2018-01-01)

Childhood autoimmune liver disease: indications and outcome of liver transplantation
por: Chai, P.F., et al.
Publicado em: (2010)

Liver and spleen stiffness measurement in the prediction of hepatocellular carcinoma in chronic liver disease
por: Anna Fichera, et al.
Publicado em: (2024-08-01)

Liver Stiffness, Not Fat Liver Content, Predicts the Length of QTc Interval in Patients with Chronic Liver Disease
por: Mattia Bellan, et al.
Publicado em: (2019-01-01)

Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis
por: Andrea Dennis, et al.
Publicado em: (2021-01-01)

The Impact of Chronic Liver Disease on Postoperative Outcomes and Resource Utilization
por: Joseph B. Oliver, et al.
Publicado em: (2021-07-01)

Stratification of disease severity in patients with liver fibrosis, cirrhosis and portal hypertension using novel multiparametric magnetic resonance imaging techniques
por: Jayaswal, ANA
Publicado em: (2019)

Fasting plasma insulin concentrations are associated with changes in hepatic fatty acid synthesis and partitioning prior to changes in liver fat content in healthy adults
por: Hodson, L, et al.
Publicado em: (2016)

Collaboration Is Needed to Translate Pharmacology Data Into Better Health Outcomes in Chronic Liver Disease
por: Rianne A. Weersink, et al.
Publicado em: (2021-04-01)